Supply Chain & Operations Services for life sciences

Delivering end-to-end supply chain strategy and transformation

Image Thumbnail


Achieving the elusive patient-centric supply chain

Supply chain resilience by design

New Science, the growth engine for the biopharma industry, helped us get through the pandemic, but inevitably added complexity and cost. The industry’s ability to adapt, lead, and thrive has activated a mindset shift from operational efficiency in individual silos, to resiliency through collaboration across silos and innovation at speed. It must be a multi-disciplinary task between R&D, regulatory affairs, procurement, manufacturing, quality, logistics and supply chain planners, united to deliver and create a more agile, resilient and sustainable pharma supply chain.

Accenture has the experience to help create future-ready supply chains that deliver across three key priorities:

  • Relevant – agile and customer-centric, addressing demand changes and scientific advances in a cost effective way
  • Resilient – preparing for, mitigating and responding to disruptions of all scales and constantly adapting to the ever-increasing complexity of New Science
  • Responsible – converting scientific advances to high quality medicines available globally by building sustainable value chains, positively impacting society and the planet while enhancing trust

Discover how we can help you sustain operations today and mobilize for tomorrow’s scientific advances and growth.

A new era in supply chain CMO collaboration

According to our research, 60% of supply chain executives (pharma/biopharma/medical device) struggle to get real-time inventory and visibility from external manufacturing partners. And yet, nearly all of them plan to expand their use of contract manufacturers in the next three years. This growth and increased complexity in life sciences supply chains requires an entirely different approach to collaboration to meet the demands of New Science and personalized treatments and devices.

In this report we bring to light the similarities and differences in the challenges both parties face and share real-world examples of where digital technology can help solve collaboration pain points. The report features companies who are getting it right and four key steps to establish a new level of supply chain collaboration.

A game-changing pharma supply chain network

When the pandemic struck, developing and deploying effective and safe vaccines as quickly as possible was a top priority. Pharmaceutical companies mobilized to create, test and get vaccines out the door to millions of people rapidly and safely. One leading biopharmaceutical company set out to be the first, rapidly developing a mRNA-based drug. Working in parallel they needed to scale up manufacturing and build a new supply chain network at record speed. As drug development progressed it became clear a game-changing new supply chain network was needed to enable lightspeed delivery and safe handling of a unique new cold chain drug. By identifying current state bottlenecks, automation opportunities and continuous improvement opportunities, we’ve helped prepare the company for ongoing vaccine supply, new formulation launches and created a blueprint for rapid future mRNA product launches.

With the pandemic, a game-changing new pharma supply chain network was needed for lightspeed delivery and safe handling of a unique new cold chain drug.

What we think

Our leaders